ResMed Inc. (RMD)
ResMed Inc. reported revenue of $5.65B for the fiscal year ended Jun 30, 2026, up 9.9% from $5.15B the year before. Net income was $1.52B, a net margin of 26.9% (prior year: $1.40B). At the end of that fiscal year the company reported total assets of $8.97B and shareholders' equity of $6.59B.
Revenue
$5.65B
+9.9% vs prior year
Net income
$1.52B
Net margin 26.9%
Diluted EPS
$10.43
USD per share
Total assets
$8.97B
At Jun 30, 2026
Equity
$6.59B
At Jun 30, 2026
Shares outstanding
141M
As of Oct 26, 2026
Explore ResMed Inc.'s filings
- Revenue by year — annual and quarterly revenue with growth rates
- Income statement & cash flow — profit, margins, EPS and operating cash flow
- Balance sheet — assets, liabilities, equity, cash and debt
- SEC filings — 10-K and 10-Q filings with links to EDGAR
Latest SEC filings
- 10-QFiled Oct 30, 2026
- 10-KFiled Aug 13, 2026
- 10-QFiled May 1, 2026
- 10-QFiled Jan 30, 2026
- 10-QFiled Oct 31, 2025
- 10-KFiled Aug 8, 2025
Source: SEC EDGAR XBRL company facts for CIK 943819 (raw data). Most recent filing in this dataset: 10-Q filed Oct 30, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.